Scalzo Richard William
SEC insider (Form 3/4/5 filer). CIK 0001789545. Chief Financial Officer at CRESCENT BIOPHARMA, INC. (CBIO) and 1 other issuer. 21 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in WALTHAM, MA.
Companies Scalzo Richard William has filed insider reports for
- CRESCENT BIOPHARMA, INC. (CBIO): Officer, Chief Financial Officer
- Dyne Therapeutics, Inc. (DYN): Officer, SVP, Head of Finance & Admin.
Scalzo Richard William
CIK: 0001789545
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Sep 16, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect568 shares at avg. $17.90$10K - Jun 22, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect1.1K shares at avg. $17.99$20K - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect14.4K shares- - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect5K shares- - Mar 11, 2025DYN
Dyne Therapeutics, Inc.
SaleDirect1.3K shares at avg. $11.38$15K - Mar 5, 2025DYN
Dyne Therapeutics, Inc.
SaleDirect917 shares at avg. $11.83$11K - Feb 18, 2025DYN
Dyne Therapeutics, Inc.
SaleDirect2.5K shares at avg. $13.95$35K - Dec 11, 2024DYN
Dyne Therapeutics, Inc.
SaleDirect1.5K shares at avg. $28.12$41K - Dec 4, 2024DYN
Dyne Therapeutics, Inc.
AwardDirect32.7K shares- - Nov 18, 2024DYN
Dyne Therapeutics, Inc.
SaleDirect2.7K shares at avg. $28.20$77K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 |  CBIO CRESCENT BIOPHARMA, INC. | Sale | 568 | $17.90 | $10,167 | Direct |
| Jun 22, 2026 | CBIO CRESCENT BIOPHARMA, INC. | Sale | 1,112 | $17.99 | $20,005 | Direct |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award | 14,422 | - | - | Direct |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award | 5,000 | - | - | Direct |
| Mar 11, 2025 |  DYN Dyne Therapeutics, Inc. | Sale | 1,343 | $11.38 | $15,283 | Direct |
| Mar 5, 2025 | DYN Dyne Therapeutics, Inc. | Sale | 917 | $11.83 | $10,848 | Direct |
| Feb 18, 2025 | DYN Dyne Therapeutics, Inc. | Sale | 2,488 | $13.95 | $34,708 | Direct |
| Dec 11, 2024 | DYN Dyne Therapeutics, Inc. | Sale | 1,455 | $28.12 | $40,915 | Direct |
| Dec 4, 2024 | DYN Dyne Therapeutics, Inc. | Award | 32,700 | - | $0 | Direct |
| Nov 18, 2024 | DYN Dyne Therapeutics, Inc. | Sale | 2,735 | $28.20 | $77,127 | Direct |
1-10 of 21 transactions